Biophysics of α-synuclein membrane interactions  by Pfefferkorn, Candace M. et al.
Biochimica et Biophysica Acta 1818 (2012) 162–171
Contents lists available at ScienceDirect
Biochimica et Biophysica Acta
j ourna l homepage: www.e lsev ie r.com/ locate /bbamemBiophysics of α-synuclein membrane interactions☆
Candace M. Pfefferkorn, Zhiping Jiang, Jennifer C. Lee ⁎
Laboratory of Molecular Biophysics, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland 20892, USA☆ This article is part of a Special Issue entitled: Me
function.
⁎ Corresponding author. Tel.: +1 301 496 3741.
E-mail address: leej4@mail.nih.gov (J.C. Lee).
0005-2736/$ – see front matter. Published by Elsevier
doi:10.1016/j.bbamem.2011.07.032a b s t r a c ta r t i c l e i n f oArticle history:
Received 2 June 2011
Received in revised form 20 July 2011
Accepted 21 July 2011
Available online 28 July 2011
Keywords:
Protein structure
Parkinson's disease
Amyloid
VesiclesMembrane proteins participate in nearly all cellular processes; however, because of experimental limitations,
their characterization lags far behind that of soluble proteins. Peripheral membrane proteins are particularly
challenging to study because of their inherent propensity to adopt multiple and/or transient conformations in
solution and upon membrane association. In this review, we summarize useful biophysical techniques for the
study of peripheral membrane proteins and their application in the characterization of the membrane
interactions of the natively unfolded and Parkinson's disease (PD) related protein, α-synuclein (α-syn). We
give particular focus to studies that have led to the current understanding of membrane-bound α-syn
structure and the elucidation of speciﬁc membrane properties that affect α-syn-membrane binding. Finally,
we discuss biophysical evidence supporting a key role for membranes and α-syn in PD pathogenesis. This
article is part of a Special Issue entitled: Membrane protein structure and function.mbrane protein structure and
B.V.Published by Elsevier B.V.1. Introduction
Though membrane proteins are predicted to constitute 15–39% of
the human proteome [1], it is striking that their structural character-
ization lags far behind that of their soluble counterparts [2–4].
Narrowing this gap in understanding is of upmost importance because
membrane proteins participate in nearly all essential cellular
processes from signaling to lipid metabolism and as such make
excellent drug targets. For example, it is remarkable that while ~45%
of drug targets are plasma membrane proteins, less than 1% of their
three dimensional structures have been determined [2]. Moreover,
membrane-mediated protein conformational changes are linked to
disease pathogenesis making the study of membrane–protein in-
teractions of particular urgency.
One of these proteins is the intrinsically disordered and amyloido-
genic protein, α-synuclein (α-syn), which is involved in Parkinson's
disease (PD) etiology [5]. In this review, we provide a brief synopsis of
some of the experimental techniques used to determine membrane–
protein structure as well as their application in the study of α-syn-
membrane interactions. Speciﬁc emphasis is given to the description
and application of biophysical methods because of their unique
advantages in the characterization and identiﬁcation of both transient
and stable membrane-bound species. We present recent work leading
to the current understanding of membrane-bound α-syn structure
and how speciﬁc membrane-properties mediate α-syn-membraneinteractions. Finally, we discuss how α-syn-membrane interactions
are linked to PD.
2. Biophysical probes of membrane protein structure
While recent advances in experimental techniques and puriﬁca-
tion procedures have facilitated the study of moremembrane–protein
systems than ever before [6], preparation of samples that retain
functionally relevant structures after puriﬁcation and/or crystalliza-
tion remains a challenge in most cases. As such, various complemen-
tary biophysical approaches (Fig. 1) in addition to conventional
structural techniques, such as solution-state nuclear magnetic
resonance (NMR) spectroscopy [7,8] and electron and X-ray crystal-
lography [9,10], have been employed to study membrane protein
secondary and tertiary structure as well as the membrane–protein
interface.
2.1. Secondary structure
Among themost common biophysical probes of secondary structure
are circular dichroism (CD), Fourier transform infrared (FTIR), and
ultraviolet resonance-Raman (UVRR) spectroscopies. CD spectroscopy,
in which the difference in left- and right-handed circularly polarized
light absorption ismeasured, allows for direct quantitation of secondary
structural content because alignments of polypeptide amide bonds
(i.e. speciﬁc alignments corresponding toα-helical,β-sheet, or random-
coil polypeptide conformations) induce distinct UV absorption bands
[11,12].
In cases where measurements of solid and/or UV opaque samples
are required, FTIR can be used since the absorption bands correspond-
ing to the amide bond stretching frequencies are also modulated by
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Fig. 1. Selected biophysical techniques used to examine membrane binding proteins
such as α-synuclein.
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emerging technique, UVRR, in which inelastic UV light scattering is
measured, can also be employed to monitor secondary structural
changes in proteins in presence of lipidmembranes [15]. One advantage
of UVRR over CD and FTIR is that by tuning into (resonance) the
aromatic absorption bands, one can obtain high sensitivity to Tyr and
Trp residues and hence the ability to characterize site-speciﬁc
environments and structure [15,16].
2.2. Tertiary structure
Though solution-state NMR is a widely used protein structural
determination technique, high concentrations of isotopically labeled
reconstituted protein is needed and the membrane bound protein
must isotropically reorient on NMR relevant time scales. The latter
point has particularly limited the use of solution-state NMR in the
structural determination of membrane proteins because protein
resonances simply disappear upon associationwith the comparatively
large phospholipid vesicles [8]. However, this NMR signal disappear-
ance can be useful for identifying residues that are membrane bound
[17]. Alternately, by using small membrane mimics such as micelles,
solution-state NMR has been quite successful in producing structural
models [18,19].
To address the problem of slow protein reorientation at the
membrane interface, oriented and magic angle spinning solid-state
NMR methods can be employed. In oriented solid-state NMR,
membranes are aligned such that anisotropy inherent in chemical
shifts, quadrupolar interactions, and dipolar couplings can be used to
extract information regarding the tilt and pitch of helices interacting
with membranes [7,20]. When alignment of the membrane is not
feasible, magic angle spinning solid-state NMR is particularly useful.
In this technique, the sample spins at an angle with respect to the
static magnetic ﬁeld in such a way that signals are signiﬁcantly
enhanced [20,21]. Using magic angle solid-state NMR, structural
information on membrane-bound proteins can be extracted including
distance and backbone dihedral angle restraints.
Distance constraints between speciﬁc residues in soluble or mem-
brane bound proteins can also be determined using Förster resonance
energy transfer (FRET) and double electron electron resonance
(DEER). In FRET, the energy transfer between ﬂuorescent donor (D)
and energy acceptor (A) molecules can be determined since the
energy transfer rate, or efﬁciency, depends on the inverse sixth power
of the distance between the D and A [22–25]. By monitoring
ﬂuorescence from proteins containing D and A molecules in the
presence and absence of membranes, changes in pairwise distances
can be extracted [26,27]. In DEER, the coupling between two residues
tagged with electron spin labels (typically between nitroxide spin
labels) can be measured and correlated to distance [28].2.3. Probes of the membrane–protein interface
Several ﬂuorescence methods can be utilized to probe site-speciﬁc
protein interactions with the membrane. Since many intrinsic and
extrinsic ﬂuorophores are highly sensitive to local environment,
changes in ﬂuorescence features (e.g.mean wavelength and quantum
yield (QY)) can indicate membrane binding. For example, upon
interaction with the hydrophobic membrane core, tryptophan
ﬂuorescence can shift by as much as 25–28 nm [29,30]. In addition
to membrane binding, differences in QY also can reﬂect interactions
with speciﬁc charged lipid headgroups or amino acid (aa) side chains
[31]. Moreover, because QY is greatly reduced in the presence of
heavy-atom quenchers such as iodide or bromine, site-speciﬁc
solvent/membrane exposure can be determined [32–35]. Using
ﬂuorescence quenching, hydrophobic α-helical regions for several
transmembrane peptides have been identiﬁed [36].
Similar determination of site-speciﬁc solvent or lipid exposure can
be accomplished using electron paramagnetic resonance (EPR). In
EPR, the interaction of unpaired electron spins in an external magnetic
ﬁeld is monitored. Though most systems do not contain unpaired
electrons, EPR spin labels can be incorporated to determine their
molecular environments. For example, EPR signals can distinguish
between a spin label in the O2 rich membrane, or the aqueous phase
by using an extrinsic probe such as nickel ethylenediamine-N-N′-
diacetic acid (NiEDDA) [37].
Fluorescence anisotropy is another method informing on site-
speciﬁc environments and membrane association. In ﬂuorescence
anisotropy, the extent of reorientation of the ﬂuorophore between
polarized excitation and emission planes is measured. Since the
degree of reorientation of the ﬂuorescence emission depends the
rotational diffusion of the ﬂuorophore, information regarding the size
and shape of the diffusing molecule and the solvent viscosity can be
extracted [38]. Anisotropy measurements are particularly useful in
the study of membrane-associating proteins, because both solvent
viscosity and size change upon membrane binding. Furthermore,
membrane-induced protein oligomerization and aggregation can be
monitored using this technique.
One promising emerging technique for the study of protein–
membrane interactions is neutron reﬂectometry [39–41]. In this
technique, neutrons impinge on a horizontally oriented sample at
small angles (b5°) and scattered neutrons aremeasured. Using neutron
reﬂectometry, the structure of deposited materials up to several
hundred nm from the surface normal can be measured with angstrom
level resolution [42]. The recent development of a solid-supported
sparsely-tethered bilayer lipid membrane (stBLM) for use in neutron
reﬂectometry has enabled simultaneous measurement of both mem-
brane properties (e.g. membrane thickness) as well membrane-bound
protein structure [43]. Neutron reﬂectometry and a stBLMhave recently
been employed to study the effect of amyloidβ oligomers onmembrane
properties [41] and the structure of functional Staphylococcus aureusα-
hemolysin channels [40].
3. α-Synuclein is a membrane protein, implicated in
Parkinson's disease
The name synuclein (syn) was ﬁrst given in 1988 to a novel 143 aa
protein isolated from the presynaptic terminals and nuclei of the
nervous tissues of the Paciﬁc electric ray, Torpedo californica [44]. Two
years later, a similar 134 aa phosphorylated protein was discovered in
bovine brain neuron synapses; however, it was named phosphoneur-
oprotein 14 [45,46]. In subsequent independent work, a hydrophobic
35 aa sequence (termed non-amyloid β component; NAC) was
identiﬁed in Alzheimer's disease amyloid plaques whose 140 aa
precursor protein was coined NACP, or non-amyloid β component
precursor protein [47]. Yet another group discovered a homolog of
NACP in zebra ﬁnch and called it synelﬁn [48].
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homologous proteins and thus, designated as α-syn. The human
homolog of phosphoneuroprotein 14 was called β-syn [49]. Subse-
quently, yet another member of the synuclein family, γ-syn, was
identiﬁed in breast cancer tissue [50].
Though the synucleins (α, β, and γ) are highly homologous [51],
and likely share similar biological functions in vivo, it isα-syn that has
gained widespread interest due to its involvement in PD etiology. PD
is a prevalent age-related neurodegenerative disease. The patholog-
ical hallmarks include cell death in the substantia nigra and the
presence of intracellular brain inclusions, or Lewy bodies, which are
comprised primarily of α-syn amyloids [5]. Further implicating α-syn
in PD are genetic ﬁndings that link early-onset PD to gene triplication
[52] and duplication [53] and three missense mutations (A30P, E46K,
and A53T) [54–56]. Other data showing that α-syn concentration
increases in nigral brain regions as a function of age [57] and recent
work demonstrating that triple α-, β-, and γ-syn knockout mice
exhibit age-dependent neuronal dysfunction provide additional
support for the tight connection between α-syn and PD [58].
α-Syn primary structure has several distinct characteristics. One
dominating feature is a series of seven imperfect amphipathic 11 aa
repeats (consensus sequence KXKEGV, Fig. 2) found in the ﬁrst 89 N-
terminal residues. These repeats, which contain charged residues
ﬂanked by paired lysine residues at the apolar-polar interface (class
A2 helix) [59] are also motifs found in the exchangeable apolipopro-
teins AII, CI, CII, and CIII [60,61]. The central region (residues 61–95),
or NAC region, is composed of nonpolar side-chains and has been
identiﬁed by numerous groups to play an important role in α-syn
aggregation and toxicity. Speciﬁcally, it was shown that deletion of
speciﬁc residues within the NAC region abolishes α-syn aggregation
[62,63], that β-syn which does not contain residues 74–84 of α-syn
does not aggregate [64], and that peptides derived from the NAC region
can formβ-sheetﬁbrils [65,66]. It alsohas been shown that isolatedNAC
peptides are toxic to cells [62,67] and that deletion of NAC residues in a
transgenic Drosophilamodel abrogates bothα-syn aggregation and cell
toxicity [68]. Lastly, the C-terminal domain of α-syn is highly acidic
(containing 15 carboxylates).
In addition to evidence from primary structure, mounting work
points toward either the direct interaction of α-syn with cellular
membranes and/or other membrane binding proteins in vivo. The
involvementofα-syn inmembrane relatedcellular function, speciﬁcally
in coordinating nuclear and synaptic events, was ﬁrst predicted based
on the localization of synuclein from the T. californica [44]. Studies on
canary α-syn further demonstrated a connection between α-syn
expression and synaptic plasticity during learning [48]. Direct evidence
for localization of α-syn near synaptic vesicles was later achieved via1  W 10        20 30 F40       50
MDVFMKGLSKAKEGVVAAAEKTKQGVAEAAGKTKEGVLYVGSKTKEGVVH
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Fig. 2. (Top) α-Synuclein primary amino acid sequence with aromatic (light blue),
acidic (red), and lysine (blue) residues highlighted. (Bottom) Schematic representation
of α-synuclein with amphipathic repeats, non-amyloid β component (NAC) region,
membrane binding domain, and acidic region in blue, light blue, gray, and red,
respectively. The location of the amphiphatic repeats, the disease-related mutations,
and the membrane binding domain also are denoted.immunogold labeling ofα-syn and visualization by electronmicroscopy
[69].
Though α-syn knockout mice do not exhibit noticeable phenotypic
changes as compared towild type (WT)mice [70,71], differences in cells
cultured from knockouts [72], in the level of dopamine release
[70,71,73], and in the quantity of the synaptic vesicle reserve pool
[74,75], point toward a role ofα-syn in synaptic vesicle trafﬁcking.More
recently, it was shown that α-syn is required for the maintenance of
continuous presynaptic SNARE (sensitive factor attachment protein
receptor) complex assembly, a complex required for neurotransmission
[76].
A correlation between mitochondrial dysfunction and PD [77] has
prompted signiﬁcant interest in α-syn-mitochondrial membrane
interaction as well. For example, it has been proposed that intracellular
acidiﬁcation resulting from oxidative or metabolic stress can induce
translocation of α-syn from the cytosol to the surface of the mito-
chondria [78]. It also has been shown using FRET-based reporters, that
the conformation of α-syn is altered in the presence of mitochondrial
membranes [79].
4. α-Synuclein interacts with model membranes
The ﬁnding that α-syn associates with membranous compartments
in cultured cells and brain tissues [48,80–82] has prompted substantial
research aimed at achieving a molecular level understanding of α-syn
interactions with model membranes. In this section, we provide an
overview of commonly used membrane mimics and physiologically
relevant lipids as well as a discussion of biophysical and biochemical
evidence regarding the effects of speciﬁc lipid headgroups, acyl chain
structure, and curvature on α-syn-membrane interactions.
4.1. Overview of membrane mimics and physiologically relevant
phospholipids
Various membrane mimics are utilized in biophysical studies of
membrane proteins in vitro. Lipid molecules, composed of hydrophilic
headgroups and hydrophobic, fatty acid tails, are frequently used
(Fig. 3A). In an aqueous environment, the amphipathic character of
lipids causes them to self assemble and sequester their hydrophobic
cores. Such assemblies are predominantly dependent on the molec-
ular shape and chemical composition. For example, lysolipids which
have one acyl chain per headgroup form micelles, whereas phospho-
lipids with two acyl chains form planar bilayers or liposome vesicles.
A vesicle is a spherical structure made of two adjacent layers of lipid
molecules in which the tails of each layer point toward each other and
headgroups face either the water-ﬁlled interior or outside environment
(Fig. 3B). Similarly, amicelle is a spherical structure inwhichhydrophilic
headgroups are in contact with the aqueous surrounding (Fig. 3B).
However, unlike a vesicle, a micelle is comprised of a single layer of
molecules with all hydrophobic tails pointing toward the center of the
micelle.
Typically, lipid vesicles (liposomes) are multilamellar (multilayer)
until the application of external mechanical forces (e.g. sonication or
vortexing) which facilitate the formation of unilamellar vesicles.
These vesicles, according to their sizes, are classiﬁed into small, large,
and giant unilamellar vesicles (SUVs: 10–100 nm, LUVs: 100 nm–
1 μm, and GUVs, N 1 μm, Fig. 3B). Unilamellar vesicles are excellent
alternatives to biomembranes as they are easy to manipulate and can
be made of deﬁned chemical composition and relative sizes. They are
good model systems for small trafﬁcking vesicles (SUVs) to cellular
membranes (GUVs). Additionally, since vesicle sizes determine curva-
ture and protein accessible surface area, these properties, which are
likely important in protein structure and function, can be investigated in
detail.
To gain insights into howα-syn interactswith biomembranes, in vitro
experiments employing membrane mimics that contain biologically
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Fig. 3. Lipid and membrane mimic structure. (A) Chemical structure of the glycerol
phospholipid and sphingolipid backbone with different headgroups (X) and their
corresponding names indicated. The R1, R2, and R designate fatty acid chains. (B)
Schematic of the approximate size and organization of membrane mimics commonly
used in biophysical research. Corresponding cellular compartments are provided for
relative size reference.
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membrane molecules in vivo include phospholipids, cholesterol, and
sphingolipids. For example, synaptic vesiclemembranes [83–86] contain
phosphatidylcholine (PC), phosphatidylethanolamine (PE), sphingo-
myelin (SM), plasmenylethanolamine, phosphatidylserine (PS), and
phosphatidylinositol (PI) (molar percent of total phospholipid: 40.9,
24.6, 12, 11.5, 7.3, and 3.7, respectively [84]) as well as phosphatidic acid
(PA) (0–2%) [87]. Synaptic vesicles also contain high levels of cholesterol
(38.5% of total lipid content) [84]. Notably, the inner and outer leaﬂets of
synaptic vesicles are asymmetric in phospholipid composition with PI
almost found exclusively in the inner leaﬂet [84]. Lipid composition
asymmetry is common for biomembranes. For example, PC and SM are
found primarily in the outer leaﬂet whereas PE and anionic phospho-
lipids such as PA, phosphatidylglycerol (PG), and PS as well as PI and
phosphoinositides (PIPs)mainly comprise the inner leaﬂet of the plasma
membrane [88].4.2. Effects of lipid headgroup and chain structure
The ﬁrst in vitro evidence that α-syn has preferential binding
afﬁnity for different lipid headgroups was reported in 1998 when it
was observed thatα-syn binds to SUVs or LUVs containing anionic but
not zwitterionic lipids [89]. This initial work prompted vigorousongoing research efforts on the effects of phospholipids on α-syn
membrane binding properties [90–94].
Generally, it is agreed that this binding preference for a negatively
charged surface is attributable to the electrostatic attraction from
multiple lysines found in the N-terminal region of α-syn (Fig. 2).
However, even under high ionic strength solution conditions (up to
500 mM), substantial helical structure is maintained suggesting that
while electrostatics play an important role in mediating α-syn-
membrane binding, they are not the sole driving force [89]. One
explanation is that the use of small headgroups may provide more
space to accommodate protein insertion [91,92,95].
While acidic headgroups are preferred, the composition of
zwitterionic lipids can also inﬂuence membrane afﬁnity. Using a
variety of techniques including ﬂuorescence correlation spectroscopy
(FCS) and CD spectroscopy, it has been shown that PE enhancesα-syn
membrane interaction [90] and that α-syn favors PA and PI over PS
and PG [90–94]. In addition to vesicles containing anionic lipids,α-syn
also can bind to lipid droplets [96] and SDS micelles [26,97–99].
It also has been shown that α-syn interacts with gangliosides
(GMs). GMs are glycosphingolipids composed of a ceramide backbone
and one or more sugars as the headgroup. Using atomic force and
confocal microscopies as well as CD spectroscopy and molecular
simulations, a number of GMs including GM1, GM2, and GM3 have
been shown to colocalize and/or interact with α-syn [100–102]. The
speciﬁcity has been rationalized by the formation of a hydrogen-
bonding network between the sugar alcohols and α-syn side chains
[101].
The lipid chain structure can inﬂuence α-syn membrane binding
as well [91,93,103]. Speciﬁcally, polyunsaturated chains are favorable
for α-syn-membrane binding [104,105]. A possible mechanism is that
the highly disordered polyunsaturated chains cause a loose packing of
membrane lipids which can lead to packing defects and thus more
space for α-syn to embed into the bilayer.
Another important lipid component is cholesterol, the major
ﬂuidity modulator of biomembranes [106]. Cholesterol, along with
other molecules such as GM1 [107], are proposed to be enriched in
lipid rafts, liquid-orderedmembrane domains that are suggested to be
involved in numerous cellular processes [108–110]. Notably, the
existence of lipid rafts in vivo is highly debated given that their
visualization in living cells is challenging [107]. In HeLa cells, α-syn
colocalized with GM1 and PI(4,5)P2 suggesting that the protein may
associate speciﬁcally with lipid rafts [100]. Interestingly, this synaptic
enrichment was observed only for WT and A53T but not the A30P
mutant.
In contrast, a confocal laser scanningmicroscopic study employing
GUVs showed that α-syn binds to anionic lipids in the liquid-
disordered phase instead of lipid rafts [111]. This result highlights the
fact that α-syn enrichment in lipid rafts remains highly controversial.
Currently, it is not clear whether α-syn simply prefers the liquid-
ordered raft environment or the particular raft components, such as
GM1 or GPI-anchored proteins. Nevertheless, since polyunsaturated
acyl chains and fatty acids of phospholipids enhance α-syn-mem-
brane binding and alter raft packing phase [112,113], it is possible that
the association of α-syn with rafts can be involved in regulation of the
subsequent cellular processes. Moreover, because PD-related, A30P
mutant behaved distinctly, it is clear that further investigations are
warranted and needed.
4.3. Effects of membrane curvature
Initial α-syn studies showed a binding preference for SUVs over
LUVs [89], indicating that surface curvature may modulate binding
afﬁnity. Subsequent FCS, site-speciﬁc ﬂuorescence, isothermal titra-
tion calorimetry, and gel-ﬁltration studies show that indeed the
membrane binding afﬁnity of α-syn is dependent on vesicle size
(curvature) [91,93,103,114]. Nevertheless, α-syn can still bind to
NC
37
3
45
92
Fig. 4. Side and top view of micelle-bound α-synuclein (PDB ID: 1XQ8). The membrane
binding domain (gray), non-amyloid β component region, and acidic region are colored
in gray, light blue, and red, respectively. Lysine residues found within the amphipathic
repeats are shown.
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Elucidating the mechanism of howα-syn senses membrane curvature
is likely pertinent to not only its physiology but also to its pathology.
In general, it is thought that at least three distinct steps are
involved in how amphipathic helices are formed at the membrane
interface [118–120]. Through long range electrostatic interactions,
polypeptide binding is initiated, followed by local rearrangement and
insertion of hydrophobic side chains, and ﬁnally α-helix folding.
Notably, there is evidence that bilayer defects are present in small
vesicles with high curvatures [121]. Thus, it is plausible that theα-syn
insertion process could be enhanced due to the presence of packing
defects in small highly curved vesicles [122].
Alternately, the binding features ofα-synmay ultimately reﬂect its
conformational ability to adapt to the chemistry of the membranes.
For example, α-syn also appears to be sensitive to lipid geometry.
Speciﬁcally, lipids with a large polar headgroup and saturated acyl
chains may limit binding while lipids with a small headgroup (e.g. PA)
and unsaturated acyl chains may promote interaction. Therefore, it is
most likely that it is the combined effects of the packing geometry of
lipid headgroups and acyl chains that contribute to the membrane
binding afﬁnity of α-syn.
5. Structural studies of membrane-bound α-synuclein
α-Syn was ﬁrst hypothesized to interact with lipid membranes
based on aa sequence and demonstrated by CD spectroscopy to adopt
an α-helical structure upon binding to both SUVs and LUVs [89]. Soon
after, NMR spectroscopy was employed by Eliezer and coworkers to
investigate its lipid-associated conformation [97]. Using SDS micelle
and synthetic phospholipid vesicles composed of POPC:POPA, it was
determined that the ﬁrst 100 residues interact with the membrane
surface, whereas the C-terminal 40 residues do not. This helical
conformation propensity was further realized to be inherent, albeit
modest (~10%) in the N-terminal region spanning residues 6 to 37
even in its soluble, unfolded state [123]. In this section, we review
subsequent biophysical studies utilizing various membrane mimics
that have contributed to our current structural understanding of
membrane bound α-syn.
5.1. A broken 11/3 α-helix
By comparison to apolipoproteins, a structural model consisting of
ﬁve amphipathic α-helices was proposed by Davidson et al. for
membrane boundα-syn [89]. Speciﬁcally, residues 1–60 form the ﬁrst
four helices (1–15, 17–37, 39–48, and 50–60) and are characterized
by basic residues, Lys, at the bilayer interface as well as the presence of
glutamates and nonpolar, hydrophobic side chains at the polar and
nonpolar face, respectively. In contrast, for helix 5 (residues 61–93) a
distinct charge distribution is not apparent and hence, it is classiﬁed
as a class G* helix [124]. However, using SDS micelles and NMR
spectroscopy, Eliezer and coworkers found contradictory evidence
and concluded the presence of only two helical regions with a short
linker [125].
In this micelle-bound model, α-syn adopts two helical regions from
residues 1–94with a break from residues Lys42 and Thr44 based on Cα
chemical shift and sequential amide proton Nuclear Overhauser Effect
data (referred to as the broken α-helix model) [125]. This folded
sequence, residues 1–103, was corroborated by limited proteolysis
analysis by mass spectrometry and N-terminal sequencing. Because a
well-deﬁned hydrophobic surface could not be generated using an
ideal helix conﬁguration anddue to thepresence of amphipathic repeats
in α-syn (Fig. 2), an 11/3 α-helix conformation was proposed as in the
case of apolipoprotein AI.
In an 11/3α-helix, there are three full turns over 11 residues (3.66
residues per turn) compared to ﬁve full turns over 18 residues in an
ideal helix (3.6 residues per turn) [125]. The break was hypothesizedto play a role in allowing the protein to bind to a range of surface
curvatures. It was suggested further that α-syn may indeed adopt a
single helical conformation upon binding a less curved surface such as
a vesicle.
5.2. NMR structure of a micelle-bound α-synuclein
Deﬁnitive structural evidence for the formation of a broken helix
uponα-syn-micelle interactionswas determined by NMR spectroscopy
and reported in 2005 by Ulmer et al. [126]. Although generally
consistent with prior work, there were minor deviations in the helical
regions; only residues 3–92 are considered to be in a helical con-
formation with residues 38–44 as the linker. Using residual dipolar
couplings and Mn2+-induced paramagnetic relaxation enhancements
labeled at residue87, themicelle-boundstructure consistedof two, anti-
parallel helices, Val3-Val37 and Lys45-Thr92, with a short, 7-residue
linker in between, followed by an extended region, Gly93-Lys97, and a
disordered C-terminal tail, Asp98-Ala140 (Fig. 4). The interhelical
distances vary and these dynamics occur on the microsecond timescale
highly suggestive of global conformational ﬂexibility on the micelle
surface.
In this structure [126], both the N- and C-terminal helices have
structural parameters closer to an ideal helix (3.6 and 3.56 residues per
turn, respectively) then the 11/3α-helix previously proposed by Eliezer
and coworkers [125]. As highlighted in Fig. 4, Lys side chains in the
repeat region point sideward from the helices which allow favorable
interactions with the acidic sulfate groups on the SDS micelle. Notably,
the helices appear to wrap themselves around the micelle with distinct
average circle diameters that substantially deviate (153 and 82 Å,
respectively) from the expected value of a SDS micelle (46 Å). This
observation implies that α-syn may prefer to form a less curved helix
and hence, upon binding, it deforms the micelle.
The structural effects of disease-related mutations, A30P and A53T
[127] as well as E46K [128] on SDS binding also have been
investigated by solution NMR spectroscopy. For both E46K and A53T
variants, local resonance perturbations near the mutations are
observed. While the A53T-micelle structure was determined to be
indistinguishable from the WT protein [127], the structural differ-
ences between micelle-bound E46K and WT remain ill-deﬁned [128].
In contrast, the replacement of Ala for Pro at residue 30 signiﬁcantly
alters the micelle-polypeptide interaction with an interruption of one
helix turn (Val26-Ala29), disruption of another (Thr22-Gly25), and
creation of a helix register shift for at least two turns. Nevertheless,
despite the substantial structural rearrangement, overall the SDS
binding property is maintained; for example, the number of residues
per turn is similar as well as the radii of curvature compared to theWT
conformation [127].
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The use of micelles as a model membrane system has been
particularly useful for structural determination and biophysical
studies [26,98,125–127,129–131]. Nevertheless, they are quite differ-
ent from biological membranes. Since the aforementioned work,
ongoing investigations using other membrane mimics and techniques
that provide distance information such as DEER [129,132–136] and
FRET [26,27,116] give additional structural insights into α-syn-
membrane interactions. Speciﬁcally, research from various groups
provides evidence that upon membrane binding α-syn can adopt an
alternative conformation, an extended [27,116,134,135,137], rather
than a broken helix [129,132]. Furthermore, given the dynamical
nature of this protein to undergo large conformational rearrange-
ments [138–140], it is even more likely that these membrane-
associated structures are not mutually exclusive and can interchange
[133,136].
The ﬁrst experimental evidence for the existence of an extended
helix was reported by Langen and coworkers using site-directed spin
labeling and continuous wave EPR spectroscopy [137]. By analyzing
47 singly labeled α-syn variants and their relative accessibilities to O2
and NiEDDA, secondary structure and topology of residues 59–90
were determined. Interestingly, the periodicity extracted yielded a
value of 3.67 residues per turn, supporting an 11/3 α-helix which was
favored by Eliezer and coworkers [125] and later ruled out based on
the SDS-micelle bound structure [126]. Subsequent DEER experiments
from 17 pairs and computational modeling [135] conﬁrmed that this
helical behavior is preserved from residues 9–89.
While there is a general consensus that membrane-bound α-syn
adopts an amphipathic α-helical structure involving approximately
the ﬁrst 100 residues, debate remains regarding the exact nature of
the interaction sites and arrangements of the helix. However, it is
likely that these differences can be accounted for by the fact that
various membrane mimics (micelle, bicelle, and vesicles), detergent/
lipid compositions, and solution conditions (pH, salt, and tempera-
ture) were employed. Perhaps even more important than the
aforementioned factors, is that experiments are performed at
different lipid-to-protein ratios, a factor which has been shown to
affect α-syn membrane binding modes [17]. Though some questions
remain, these results highlight the likely propensity for α-syn to
undergo signiﬁcant structural rearrangements under different solu-
tion conditions, an inherent trait whichmay be related to the function
of α-syn in vivo.5.4. Multiple binding modes and conformational heterogeneity
Based on the disappearance of solution NMR signals, it was shown
that multiple distinct phospholipid binding modes exist forα-syn and
that these modes can be tuned by changing the lipid-to-protein ratio
[17]. Speciﬁcally, two distinct binding modes were characterized, SL1
and SL2, corresponding to the association of the ﬁrst 25 and 97
residues, respectively. As the lipid-to-protein ratio was increased, a
smooth progression was observed in the ratio of the SL1 to SL2
binding modes [17]. Evidence for the presence of multiple-membrane
bound conformations also can be found in time-resolved trypto-
phan ﬂuorescence data showing increased heterogeneity near the
C-terminal site, W94, compared to that of the N-terminal probe, W4
[115]. The idea that different regions of α-syn can associate with the
membrane under different solution conditions is further corrobo-
rated by a recent study of the role of the N-terminus in α-syn mem-
brane binding [141]. In this study, it was found that different isolated
regions of the α-syn sequence bind to membranes to different
degrees and that secondary structural formation for each of these
regions is dependent on lipid composition as well as other factors
such as temperature [141].6. Involvement of α-synuclein membrane interactions in
Parkinson's disease pathogenesis
Despite a general consensus regarding the participation of α-syn
in PD [5,142], intensive research efforts are still devoted to elucidating
the role of α-syn-membrane interactions in pathogenesis. One link is
that the presence of disease-related mutations modulates α-syn
membrane binding in vitro [111,114,143–147]. Moreover, as PD is
classiﬁed as a protein misfolding disease [148,149], perhaps the most
compelling biophysical evidence is that the presence of membranes
affects α-syn secondary structure in vitro [89]. Upon membrane
binding, changes in the protein folding landscape ensue such that the
energy barriers inhibiting the formation of potentially toxic, oligo-
meric or β-sheet structures are lowered. Another mechanism,
supported by mounting biophysical data, is that α-syn membrane-
binding results in membrane instability and/or permeabilization, both
of which could impact various in vivo processes.
6.1. Effect of disease-related mutations on membrane binding
Disparities in the membrane binding properties of WT and PD-
related mutant α-synucleins were ﬁrst noted in 1998 when it was
reported that WT and A53T bound to rat brain vesicles whereas A30P
did not [145]. Although to varying degrees, subsequent studies revealed
further differences between the membrane afﬁnity of WT and A30P. In
2000, Perrin et al. showed using site directed mutagenesis and CD
spectroscopy that the familial mutants had little (A30P) or no (A53T)
effect on lipid binding or α-helicity [147]. In contrast, using ultracen-
trifugation, CD spectroscopy, and low-angle X-ray diffraction, Jo et al.
found that A30P was defective in binding while A53T almost showed a
comparable binding ability to WT α-syn [146]. Bussell et al. later
conﬁrmed that A30P, but not A53T, decreased lipid binding afﬁnity
[143].
Though some inconsistencies between the relative effects of the
A30P and A53Tmutation onmembrane binding subsist, it is likely that
these differences can be accounted for by the fact that experiments
were performed using model membranes of different composition
and size and under different solution conditions (vide supra). For
example, in an isothermal calorimetry study, it was shown that A30P
shared a similar binding afﬁnity to WT in a gel phase (e.g. DPPC)
whereas binding was weaker in the liquid crystalline phase (e.g.
DOPC/DOPG) as compared toWT [114]. Moreover, it was shown using
anionic GUVs that the A30P protein bound less efﬁciently compared to
WT α-syn [111].
Though less research has been conducted on the effects of the
E46K mutant due to its more recent discovery [56], unlike A30P, the
presence of E46K generally increases α-syn membrane afﬁnity
[111,144]. This increased afﬁnity is likely due to the introduction of
an additional positive charge which enhances electrostatic forces.
Whether the membrane afﬁnity is increased (E46K) or decreased
(A30P), it is clear that under certain solution conditions the presence
of mutations can modulate the equilibrium between solution and
membrane-bound conformations.
6.2. Membrane mediated α-synuclein oligomer formation and
aggregation
It is unclear whether the β-sheet structure found in the Lewy
bodies of PD patients are protective or toxic to cells in the body;
however, substantial evidence show that the presence of membranes
or membrane mimics can modulate the formation of β-sheets in vitro
[150–152]. One possibility is that the membrane surface facilitates a
local increase in α-syn concentration and therefore, stimulates
aggregation [18,153]. This reasoning is attractive because it is
known that increased expression of α-syn caused by gene triplication
or duplication leads to early onset PD [52,53].
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ratio of protein-to-membrane mimic in solution [151,152]. This
observation is consistent with another possibility that membrane
binding induces the formation of toxic or aggregation-prone oligo-
mers. This idea ﬁrst was discussed in the context of CD data showing
that α-syn aggregation rate is correlated to the level of α-helicity
(partial and saturating helicity correspond to accelerated or slowed
aggregation, respectively) [151,152]. This suggestion that membranes
promote oligomer formation is supported by other studies [154]. For
example, EPR data on SUVs bound α-syn, reveal a membrane induced
dimeric structure [155]. In another recent report, a triﬂuoroethanol
(TFE) induced partially helical monomeric species of α-syn was
characterized and associated with enhanced ﬁbril formation [156].
Interestingly, though disease-related mutants (A30P, E46K, A53T)
exhibited similar TFE-induced secondary structure, oligomerization
rates differed substantially as compared to WT protein, bolstering the
connection between membranes and PD pathogenesis [156].
Substantial experimental data also support a likely prominent role
of membranes in modulating α-syn oligomerization and/or protein
aggregation in vivo. In the presence of isolated brain fractions, α-syn
was found to aggregate, whereas no aggregates were detected in the
cytosolic fraction [157]. The addition of membrane-bound α-syn also
was found to seed aggregation in the cytosolic fraction [157].
Moreover, chemical cross-linking experiments in cells treated with
high concentrations of fatty acids show that α-syn forms dimers and
trimers that preferentially associate with the phospholipid mono-
layers surrounding triglyceride-rich lipid droplets as well as other
cellular membranes [96]. Interestingly, while the PD related mutant
E46K also localized to the lipid droplets and membranes, A30P
remained cytosolic.
6.3. α-Synuclein induced membrane perturbation
One mechanism through which amyloidogenic proteins can cause
cellular dysfunction is by inducing instability in membranes [158–161].
In 2001, it was shown that protoﬁbrillar α-syn can cause transient
permeabilization in anionic membranes and thus alter the calcium ﬂux
into the cytosol, depolarization of mitochondrial membranes, and/or
leakage of intra-vesicular neurotransmitter molecules, such as dopa-
mine [162]. Notably, later it was shown that protoﬁbril induced
membrane leakage is increased when disease-related mutations are
present (A30P and A53T) [163].
Numerous other studies have since conﬁrmed that indeed various
conformations of α-syn can cause membrane instability and even
pore formation. For example, using atomic force microscopy and
vesicle dye leakage assays, it was shown that membrane disruption is
positively correlated to α-syn membrane afﬁnity and that ﬁbrillar, as
well as oligomeric, α-syn enhances membrane permeability [152].
The presence of WT, E46K, and A53T protein can induce formation of
ion channels in anionic SUVs, whereas A30P did not under similar
solution conditions [164].
Van Rooijen et al. showed that the presence of anionic lipids and
lipid-disordered domains affects the ability of α-syn to perturb
membranes [94,165], offering new insight into the speciﬁc conditions
promoting membrane disruption. Subsequent study revealed that
disruption of vesicles is caused by non-equilibrium processes and
despite rapid dye efﬂux from vesicles, membrane morphology is
maintained in the presence of oligomeric α-syn [166].
Taking advantage of solid-state NMR and EPRmethods, it has been
determined that α-syn pores are comprised of β-sheet structures
unique from those found in amyloid ﬁbrils [167]. Moreover, a low
resolution wreath shaped α-syn oligomer was identiﬁed by X-ray
scattering methods and was shown to disrupt liposomes [168].
Though the speciﬁc mechanism of membrane disruption is yet to
be determined, several recent reports have demonstrated that α-syn
also can transform membrane surface topology. This phenomenonwas brought to light when it was found that the addition of α-syn to
SUVs induced tubular structures as well as multilamellar and
branched vesicles [17,168]. Further work showed that α-syn can
increase membrane curvature causing smaller vesicles and tubules to
form [169]. Accordingly, ﬂuorescence microscopic studies on sup-
ported lipid bilayers also reveal tubule formation as well as a
correlation between increased tubulation and the presence of anionic
lipids and disease-related mutations [170].
7. Concluding remarks
The ﬁnding that α-syn membrane interactions are linked not only
to its biological function but also to its role in the etiology of PD points
to the importance of development and application of biophysical
approaches to determine protein conformation and dynamics in the
presence of biomembranes. Though signiﬁcant advancements in our
understanding of the α-syn-membrane interface have been made, a
crucial question is whether and how interactions with a phospholipid
membrane surface can conformationally alter (misfold) α-syn and
thus promote protein oligomerization. Furthermore, it is still
debatable if and how membrane induced misfolded structures are
directly involved in the pathogenicmechanism of PD. A partial answer
may be found from an increased understanding of the protein–
membrane interface provided us through advancements in solid-state
NMR and neutron reﬂectometry techniques.
Numerous studies emphasize that even upon membrane binding,
thehelicalα-syn conformers remain a dynamical polypeptide ensemble
that is highly sensitive to speciﬁc solution conditions. Importantly,
modiﬁcations of solution conditions, phospholipid compositions, and aa
sequence do not necessarily produce unique conformational changes.
These observations underscore the signiﬁcance of biophysical tech-
niques that can provide insights into the properties of dynamic and
heterogeneous ensemble ofα-syn polypeptides in solution,membrane-
associated, and ﬁnally, in its amyloid form.
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